News und Analysen
EQS-Adhoc: DWS Group GmbH & Co. KGaA: Proposed dividend pay-out
EQS-Adhoc: DWS Group GmbH & Co. KGaA: Proposed dividend pay-out
EQS-News: Dermapharm Holding SE successfully maintains growth trend as planned
EQS-News: Dermapharm Holding SE successfully maintains growth trend as planned
EQS-News: Q3 2022: DWS with Higher Revenues and Return to Net Inflows in Challenging Environment
EQS-News: Q3 2022: DWS with Higher Revenues and Return to Net Inflows in Challenging Environment
DGAP-News: Dermapharm Holding SE publishes H1 2022 financial report, confirms outlook for 2022 overall
DGAP-News: Dermapharm Holding SE publishes H1 2022 financial report, confirms outlook for 2022 overall
DGAP-News: Dermapharm Holding SE: Successful first half of 2022 in challenging market environment
DGAP-News: Dermapharm Holding SE: Successful first half of 2022 in challenging market environment
DGAP-News: Dermapharm commits to acquire the French market leader for herbal medicinal products and food supplements
DGAP-News: Dermapharm commits to acquire the French market leader for herbal medicinal products and food supplements
DGAP-Adhoc: Dermapharm Holding SE: binding offer to acquire Arkopharma Group
DGAP-Adhoc: Dermapharm Holding SE: binding offer to acquire Arkopharma Group
DGAP-News: Q2 2022: DWS Stays Resilient with Strong Financial Results in Turbulent Markets
DGAP-News: Q2 2022: DWS Stays Resilient with Strong Financial Results in Turbulent Markets
DGAP-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 2.17 per share
DGAP-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 2.17 per share
DGAP-Adhoc: DWS Group GmbH & Co. KGaA: Stefan Hoops appointed new CEO of DWS as Asoka Wöhrmann resigns
DGAP-Adhoc: DWS Group GmbH & Co. KGaA: Stefan Hoops appointed new CEO of DWS as Asoka Wöhrmann resigns
DGAP-News: Dermapharm Holding SE: excellent start into financial year 2022
DGAP-News: Dermapharm Holding SE: excellent start into financial year 2022
DGAP-News: Q1 2022: DWS With Resilience and Strong Financial Results
DGAP-News: Q1 2022: DWS With Resilience and Strong Financial Results
DGAP-News: Dermapharm Holding SE records best ever year in 2021 - continuous growth in financial year 2022
DGAP-News: Dermapharm Holding SE records best ever year in 2021 - continuous growth in financial year 2022
DGAP-News: Dermapharm Holding SE: 2021 erfolgreichstes Jahr der Firmengeschichte - kontinuierliches Wachstum im Geschäftsjahr 2022
DGAP-News: Dermapharm Holding SE: 2021 erfolgreichstes Jahr der Firmengeschichte - kontinuierliches Wachstum im Geschäftsjahr 2022
DGAP-News: Dermapharm Holding SE: Kontinuierliches Wachstum von Konzernumsatz und bereinigtem Konzern-EBITDA in 2022
DGAP-News: Dermapharm Holding SE: Kontinuierliches Wachstum von Konzernumsatz und bereinigtem Konzern-EBITDA in 2022
DGAP-News: Dermapharm Holding SE: Continuous growth of Group revenues and adjusted Group EBITDA in 2022
DGAP-News: Dermapharm Holding SE: Continuous growth of Group revenues and adjusted Group EBITDA in 2022
DGAP-News: Dermapharm Holding SE: Erfolgreichstes Geschäftsjahr der Firmengeschichte - bereinigtes Konzern-EBITDA am oberen Ende der Prognose
DGAP-News: Dermapharm Holding SE: Erfolgreichstes Geschäftsjahr der Firmengeschichte - bereinigtes Konzern-EBITDA am oberen Ende der Prognose
DGAP-News: Dermapharm Holding SE: Most successful business year in the company's history - Adjusted Group EBITDA at the upper end of the outlook
DGAP-News: Dermapharm Holding SE: Most successful business year in the company's history - Adjusted Group EBITDA at the upper end of the outlook
DGAP-News: Dermapharm akquiriert erfolgreich C³-Gruppe
DGAP-News: Dermapharm akquiriert erfolgreich C³-Gruppe
DGAP-News: Dermapharm successfully acquires C³ Group
DGAP-News: Dermapharm successfully acquires C³ Group
DGAP-News: DWS 2021: A Year for the Record Books in Profit, CIR, Flows, AuM
DGAP-News: DWS 2021: A Year for the Record Books in Profit, CIR, Flows, AuM
DGAP-News: DWS 2021: Ein Jahr der Rekorde bei Gewinn, Aufwand-Ertrags-Relation, Nettomittelzuflüssen und verwaltetem Vermögen
DGAP-News: DWS 2021: Ein Jahr der Rekorde bei Gewinn, Aufwand-Ertrags-Relation, Nettomittelzuflüssen und verwaltetem Vermögen
DGAP-Adhoc: DWS Group GmbH & Co. KGaA: Ergebnisse des vierten Quartals übertreffen Analystenerwartungen
DGAP-Adhoc: DWS Group GmbH & Co. KGaA: Ergebnisse des vierten Quartals übertreffen Analystenerwartungen
DGAP-Adhoc: DWS Group GmbH & Co. KGaA: Fourth quarter results exceed analyst expectations
DGAP-Adhoc: DWS Group GmbH & Co. KGaA: Fourth quarter results exceed analyst expectations
DGAP-News: Dermapharm Holding SE erhöht EBITDA-Prognose für das Gesamtjahr 2021
DGAP-News: Dermapharm Holding SE erhöht EBITDA-Prognose für das Gesamtjahr 2021